UA89040C2 - Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds - Google Patents
Glucopyranosyl-substituted benzol derivatives, drugs containing said compoundsInfo
- Publication number
- UA89040C2 UA89040C2 UAA200610843A UAA200610843A UA89040C2 UA 89040 C2 UA89040 C2 UA 89040C2 UA A200610843 A UAA200610843 A UA A200610843A UA A200610843 A UAA200610843 A UA A200610843A UA 89040 C2 UA89040 C2 UA 89040C2
- Authority
- UA
- Ukraine
- Prior art keywords
- compounds
- glucopyranosyl
- drugs containing
- benzol derivatives
- substituted benzol
- Prior art date
Links
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical class C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000003814 drug Chemical class 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to glucopy-ranosyl-substituted benzol derivatives of general formula (I), wherein rests Rto Rand R, R, Rare such as defined in the claim 1, including the tautomers, stereoisomers, mixtures and the salts thereof. The inventive compounds are useful for treating metabolic diseases.(І)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004012676A DE102004012676A1 (en) | 2004-03-16 | 2004-03-16 | New glucopyranosyl-substituted benzene derivatives are sodium-dependent glucose cotransporter inhibitors, useful for treating e.g. metabolic disorders (type 1 and type 2 diabetes mellitus or metabolic acidosis) |
Publications (1)
Publication Number | Publication Date |
---|---|
UA89040C2 true UA89040C2 (en) | 2009-12-25 |
Family
ID=35044978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200610843A UA89040C2 (en) | 2004-03-16 | 2005-03-11 | Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds |
Country Status (4)
Country | Link |
---|---|
CN (1) | CN1930141A (en) |
DE (1) | DE102004012676A1 (en) |
UA (1) | UA89040C2 (en) |
ZA (1) | ZA200605511B (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7772191B2 (en) | 2005-05-10 | 2010-08-10 | Boehringer Ingelheim International Gmbh | Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein |
CN101652377A (en) * | 2007-04-02 | 2010-02-17 | 泰拉科斯有限公司 | Benzylic glycoside derivatives and methods of use |
CN101343296B (en) * | 2007-07-10 | 2013-04-10 | 莱西肯医药有限公司 | Inhibitors of sodium glucose co-transporter 2 and methods of their use |
HUE035947T2 (en) * | 2007-08-23 | 2018-06-28 | Theracos Sub Llc | (2s,3r,4r,5s,6r)-2-(4-chloro-3-benzylphenyl)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol derivatives for use in the treatment of diabetes |
CN101503399B (en) * | 2008-02-04 | 2012-06-27 | 白鹭医药技术(上海)有限公司 | C-aryl glucoside SGLT2 inhibitor |
CA2733795C (en) * | 2008-08-28 | 2013-12-31 | Pfizer Inc. | Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives |
UY32441A (en) * | 2009-02-13 | 2010-09-30 | Boehringer Ingelheim Int | PHARMACEUTICAL COMPOSITION, TREATMENT METHODS AND ITS USES |
NZ594024A (en) * | 2009-02-13 | 2013-08-30 | Boehringer Ingelheim Int | Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient |
WO2011039108A2 (en) * | 2009-09-30 | 2011-04-07 | Boehringer Ingelheim International Gmbh | Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives |
CA2775961C (en) * | 2009-09-30 | 2017-11-07 | Boehringer Ingelheim International Gmbh | Method for the preparation of a crystalline form of 1-chloro-4-(beta-d-glucopyranos-1-yl)-2-(4-((s)-tetrahydrofuran-3-yloxy)benzyl)benzene |
RS55909B1 (en) * | 2009-10-14 | 2017-09-29 | Janssen Pharmaceutica Nv | Process for the preparation of compounds useful as inhibitors of sglt2 |
US20120283169A1 (en) * | 2010-11-08 | 2012-11-08 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
US8980829B2 (en) | 2011-02-18 | 2015-03-17 | Shanghai Yingli Science And Technology Co., Ltd | Aryl glycoside compound, preparation method and use thereof |
WO2012165914A2 (en) * | 2011-06-01 | 2012-12-06 | Green Cross Corporation | Novel diphenylmethane derivatives as sglt2 inhibitors |
EP2725031B1 (en) * | 2011-06-25 | 2016-08-03 | Xuanzhu Pharma Co., Ltd. | C-glycoside derivatives |
US9193751B2 (en) | 2012-04-10 | 2015-11-24 | Theracos, Inc. | Process for the preparation of benzylbenzene SGLT2 inhibitors |
CN104045513A (en) * | 2013-03-14 | 2014-09-17 | 爱康药业有限公司 | 4-substituted-1-chloro-2-(4-fluorobenzyl)benzene, its preparation method and application as intermediate in preparation of anti-type II diabetes drugs |
US20140303097A1 (en) | 2013-04-05 | 2014-10-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
CA2812519A1 (en) * | 2013-04-05 | 2014-10-05 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
PT2981271T (en) | 2013-04-05 | 2019-02-19 | Boehringer Ingelheim Int | Therapeutic uses of empagliflozin |
US11813275B2 (en) | 2013-04-05 | 2023-11-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
DK2986304T3 (en) | 2013-04-18 | 2022-04-04 | Boehringer Ingelheim Int | PHARMACEUTICAL COMPOSITION, TREATMENT PROCEDURES AND USES. |
CN104513283B (en) * | 2013-09-27 | 2018-01-16 | 广东东阳光药业有限公司 | Glucopyranosyl derivatives and its application in medicine |
US9315438B2 (en) | 2014-01-03 | 2016-04-19 | Xuanzhu Pharma Co., Ltd | Optically pure benzyl-4-chlorophenyl-C-glucoside derivative |
AU2018295540B2 (en) * | 2017-07-04 | 2023-05-25 | Intocell, Inc. | Compounds comprising cleavable linker and uses thereof |
CN110117300A (en) * | 2018-04-23 | 2019-08-13 | 中国科学院成都生物研究所 | Medicinal usage comprising white 1 inhibitor of sodium glucose co-transporter 2 |
CN108610385A (en) * | 2018-04-23 | 2018-10-02 | 中国科学院成都生物研究所 | A kind of medicinal usage of white 1 inhibitor of sodium glucose co-transporter 2 |
WO2023104201A1 (en) * | 2021-12-09 | 2023-06-15 | 珠海市藤栢医药有限公司 | Aryl c-glucoside derivative, preparation method therefor and use thereof |
CN115991702B (en) * | 2021-12-09 | 2024-02-02 | 珠海市藤栢医药有限公司 | Aryl C-glucoside derivative, preparation method and application thereof |
-
2004
- 2004-03-16 DE DE102004012676A patent/DE102004012676A1/en not_active Withdrawn
-
2005
- 2005-03-11 UA UAA200610843A patent/UA89040C2/en unknown
- 2005-03-11 CN CNA2005800069449A patent/CN1930141A/en active Pending
-
2006
- 2006-07-04 ZA ZA200605511A patent/ZA200605511B/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE102004012676A1 (en) | 2005-10-06 |
ZA200605511B (en) | 2007-11-28 |
CN1930141A (en) | 2007-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA89040C2 (en) | Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds | |
WO2005092877A8 (en) | Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof | |
TW200635599A (en) | Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture | |
TW200643013A (en) | Pyrazoles | |
TW200801029A (en) | Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture | |
MXPA05010712A (en) | Quinoline-2-one-derivatives for the treatment of airways diseases. | |
MXPA04003759A (en) | N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors. | |
WO2008055870A8 (en) | Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture | |
WO2008034859A8 (en) | Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture | |
JO2282B1 (en) | Oxazol derivatives | |
MX2009006742A (en) | Novel compounds. | |
EA011086B9 (en) | Proline derivatives and their use as dipeptidyl peptidase iv inhibitors | |
UA92637C2 (en) | Pyridine[3,4-b]pyrazinones | |
NO20082496L (en) | pyrazine derivatives | |
UA92355C2 (en) | urn:schemas-microsoft-com:office:smarttags2,4-DIAMINO-PYRIMIDINES USED AS AURORAINHIBITORS | |
TW200505919A (en) | DPP-IV inhibitors | |
MX2007002398A (en) | New pharmaceutical compositions for the treatment of cancer. | |
MY149622A (en) | Pyrazoles as 11-beta-hsd-1 | |
WO2005110994A8 (en) | Substituted pyrazolyl urea derivatives useful in the treatment of cancer | |
HK1079522A1 (en) | Thienyl compounds | |
MX2007010072A (en) | Antibacterial piperidine derivatives. | |
MX2007000505A (en) | Substituted oxindol derivatives and medicaments containing the same. | |
HK1080470A1 (en) | Heterocyclic compounds | |
DE602006009095D1 (en) | Diacylglycerol-acyltransferase-hemmer | |
MXPA04006184A (en) | 1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor. |